These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26039257)

  • 1. L-type calcium channels as drug targets in CNS disorders.
    Ortner NJ; Striessnig J
    Channels (Austin); 2016; 10(1):7-13. PubMed ID: 26039257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?
    Striessnig J; Ortner NJ; Pinggera A
    Curr Mol Pharmacol; 2015; 8(2):110-22. PubMed ID: 25966690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.
    Zamponi GW; Striessnig J; Koschak A; Dolphin AC
    Pharmacol Rev; 2015 Oct; 67(4):821-70. PubMed ID: 26362469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
    Calorio C; Gavello D; Guarina L; Salio C; Sassoè-Pognetto M; Riganti C; Bianchi FT; Hofer NT; Tuluc P; Obermair GJ; Defilippi P; Balzac F; Turco E; Bett GC; Rasmusson RL; Carbone E
    J Physiol; 2019 Mar; 597(6):1705-1733. PubMed ID: 30629744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.
    Huang H; Ng CY; Yu D; Zhai J; Lam Y; Soong TW
    Nat Commun; 2014 Jul; 5():4481. PubMed ID: 25057870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and pharmacological modulation of the embryonic skeletal muscle calcium channel splice variant CaV1.1e.
    Benedetti B; Tuluc P; Mastrolia V; Dlaska C; Flucher BE
    Biophys J; 2015 Mar; 108(5):1072-80. PubMed ID: 25762319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering selectivity into RGK GTPase inhibition of voltage-dependent calcium channels.
    Puckerin AA; Chang DD; Shuja Z; Choudhury P; Scholz J; Colecraft HM
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12051-12056. PubMed ID: 30397133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Exon 8/8a Splicing by Downregulated PTBP (Polypyrimidine Tract-Binding Protein) 1 Increases Ca
    Lei J; Liu X; Song M; Zhou Y; Fan J; Shen X; Xu X; Kapoor I; Zhu G; Wang (王觉进) J
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2440-2453. PubMed ID: 32787518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation.
    Koschak A; Reimer D; Walter D; Hoda JC; Heinzle T; Grabner M; Striessnig J
    J Neurosci; 2003 Jul; 23(14):6041-9. PubMed ID: 12853422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.
    Berger SM; Bartsch D
    Cell Tissue Res; 2014 Aug; 357(2):463-76. PubMed ID: 24996399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol moderately inhibits cardiovascular L-type calcium current.
    Tarabová B; Nováková M; Lacinová L
    Gen Physiol Biophys; 2009 Sep; 28(3):249-59. PubMed ID: 20037190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-type Ca
    Striessnig J; Pinggera A; Kaur G; Bock G; Tuluc P
    Wiley Interdiscip Rev Membr Transp Signal; 2014 Mar; 3(2):15-38. PubMed ID: 24683526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT
    Bernhem K; Krishnan K; Bondar A; Brismar H; Aperia A; Scott L
    BMC Cardiovasc Disord; 2017 May; 17(1):126. PubMed ID: 28514967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity complexes of pannexin channels and L-type calcium channel splice-variants in human lung: Possible role in clevidipine-induced dyspnea relief in acute heart failure.
    Dahl GP; Conner GE; Qiu F; Wang J; Spindler E; Campagna JA; Larsson HP
    EBioMedicine; 2016 Aug; 10():291-7. PubMed ID: 27349457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrodotoxin blocks native cardiac L-type calcium channels but not CaV1.2 channels expressed in HEK cells.
    Szentandrassy N; Papp F; Hegyi B; Bartok A; Krasznai Z; Nanasi PP
    J Physiol Pharmacol; 2013 Dec; 64(6):807-10. PubMed ID: 24388896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide inhibited L-type calcium channels (CaV1.2) via up-regulation of the channel sulfhydration in vascular smooth muscle cells.
    Dai L; Qian Y; Zhou J; Zhu C; Jin L; Li S
    Eur J Pharmacol; 2019 Sep; 858():172455. PubMed ID: 31202801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CACNA1C (Ca
    Harrison PJ; Husain SM; Lee H; Los Angeles A; Colbourne L; Mould A; Hall NAL; Haerty W; Tunbridge EM
    Neuropharmacology; 2022 Dec; 220():109262. PubMed ID: 36154842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaV1.2 and CaV1.3 voltage-gated L-type Ca2+ channels in rat white fat adipocytes.
    Fedorenko OA; Pulbutr P; Banke E; Akaniro-Ejim NE; Bentley DC; Olofsson CS; Chan S; Smith PA
    J Endocrinol; 2020 Feb; 244(2):369-381. PubMed ID: 31770099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells.
    Marcantoni A; Vandael DH; Mahapatra S; Carabelli V; Sinnegger-Brauns MJ; Striessnig J; Carbone E
    J Neurosci; 2010 Jan; 30(2):491-504. PubMed ID: 20071512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug targets in the voltage-gated calcium channel family: why some are and some are not.
    Triggle DJ
    Assay Drug Dev Technol; 2003 Oct; 1(5):719-33. PubMed ID: 15090244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.